Annual CFI
-$1.03 B
-$1.03 B-754545.59%
31 December 2023
Summary:
Ironwood Pharmaceuticals annual cash flow from investing activities is currently -$1.03 billion, with the most recent change of -$1.03 billion (-754545.59%) on 31 December 2023. During the last 3 years, it has fallen by -$1.03 billion (-387189.81%). IRWD annual CFI is now -777.62% below its all-time high of $151.46 million, reached on 31 December 2017.IRWD Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$16.00 K
+$42.00 K+72.41%
30 September 2024
Summary:
Ironwood Pharmaceuticals quarterly cash flow from investing activities is currently -$16.00 thousand, with the most recent change of +$42.00 thousand (+72.41%) on 30 September 2024. Over the past year, it has increased by +$4.17 million (+99.62%). IRWD quarterly CFI is now -100.02% below its all-time high of $88.06 million, reached on 31 March 2017.IRWD Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$4.33 M
+$22.61 M+83.93%
30 September 2024
Summary:
Ironwood Pharmaceuticals TTM cash flow from investing activities is currently -$4.33 million, with the most recent change of +$22.61 million (+83.93%) on 30 September 2024. Over the past year, it has increased by +$1.02 billion (+99.58%). IRWD TTM CFI is now -102.86% below its all-time high of $151.46 million, reached on 31 December 2017.IRWD TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IRWD Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +99.6% | +99.6% |
| 3 y3 years | -10000.0% | +87.5% | -1534.0% |
| 5 y5 years | -9109.6% | +99.4% | +61.1% |
IRWD Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | -159.3% | +100.0% | -3083.8% | +99.6% |
| 5 y | 5 years | <-9999.0% | at low | -159.3% | +100.0% | <-9999.0% | +99.6% |
| alltime | all time | -777.6% | at low | -100.0% | +100.0% | -102.9% | +99.6% |
Ironwood Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.00 K(-72.4%) | -$4.33 M(-83.9%) |
| June 2024 | - | -$58.00 K(-14.7%) | -$26.94 M(-97.4%) |
| Mar 2024 | - | -$68.00 K(-98.4%) | -$1.03 B(+0.0%) |
| Dec 2023 | -$1.03 B(>+9900.0%) | -$4.19 M(-81.5%) | -$1.03 B(+0.4%) |
| Sept 2023 | - | -$22.63 M(-97.7%) | -$1.02 B(+2.3%) |
| June 2023 | - | -$999.49 M(>+9900.0%) | -$999.54 M(>+9900.0%) |
| Mar 2023 | - | -$13.00 K(-148.1%) | -$140.00 K(+2.9%) |
| Dec 2022 | -$136.00 K(-48.7%) | $27.00 K(-140.9%) | -$136.00 K(-53.3%) |
| Sept 2022 | - | -$66.00 K(-25.0%) | -$291.00 K(-19.6%) |
| June 2022 | - | -$88.00 K(+877.8%) | -$362.00 K(+32.1%) |
| Mar 2022 | - | -$9000.00(-93.0%) | -$274.00 K(+3.4%) |
| Dec 2021 | -$265.00 K(-85.6%) | -$128.00 K(-6.6%) | -$265.00 K(+60.6%) |
| Sept 2021 | - | -$137.00 K(<-9900.0%) | -$165.00 K(+489.3%) |
| June 2021 | - | $0.00(0.0%) | -$28.00 K(-93.1%) |
| Mar 2021 | - | $0.00(-100.0%) | -$404.00 K(-78.1%) |
| Dec 2020 | -$1.84 M(-83.5%) | -$28.00 K(<-9900.0%) | -$1.84 M(-58.8%) |
| Sept 2020 | - | $0.00(-100.0%) | -$4.47 M(-40.7%) |
| June 2020 | - | -$376.00 K(-73.9%) | -$7.55 M(-21.4%) |
| Mar 2020 | - | -$1.44 M(-46.0%) | -$9.61 M(-13.8%) |
| Dec 2019 | -$11.14 M(-112.5%) | -$2.66 M(-13.5%) | -$11.14 M(-223.8%) |
| Sept 2019 | - | -$3.08 M(+26.7%) | $9.01 M(-65.8%) |
| June 2019 | - | -$2.43 M(-18.4%) | $26.37 M(-36.1%) |
| Mar 2019 | - | -$2.98 M(-117.0%) | $41.24 M(-53.6%) |
| Dec 2018 | $88.87 M(-41.3%) | $17.49 M(+22.4%) | $88.87 M(+136.8%) |
| Sept 2018 | - | $14.29 M(+14.8%) | $37.52 M(-24.8%) |
| June 2018 | - | $12.44 M(-72.1%) | $49.90 M(-53.8%) |
| Mar 2018 | - | $44.65 M(-231.9%) | $108.05 M(-28.7%) |
| Dec 2017 | $151.46 M(-185.2%) | -$33.85 M(-227.0%) | $151.46 M(+116.7%) |
| Sept 2017 | - | $26.66 M(-62.2%) | $69.89 M(-248.3%) |
| June 2017 | - | $70.59 M(-19.8%) | -$47.13 M(-58.3%) |
| Mar 2017 | - | $88.06 M(-176.3%) | -$112.96 M(-36.4%) |
| Dec 2016 | -$177.67 M | -$115.42 M(+27.7%) | -$177.67 M(+549.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2016 | - | -$90.36 M(-1997.1%) | -$27.34 M(-132.2%) |
| June 2016 | - | $4.76 M(-79.6%) | $84.86 M(-1624.5%) |
| Mar 2016 | - | $23.35 M(-33.1%) | -$5.57 M(-39.2%) |
| Dec 2015 | -$9.15 M(-83.8%) | $34.91 M(+59.9%) | -$9.15 M(+59.0%) |
| Sept 2015 | - | $21.83 M(-125.5%) | -$5.75 M(-83.8%) |
| June 2015 | - | -$85.66 M(-533.5%) | -$35.47 M(+16.9%) |
| Mar 2015 | - | $19.76 M(-48.4%) | -$30.34 M(-46.4%) |
| Dec 2014 | -$56.57 M(-44.2%) | $38.31 M(-586.0%) | -$56.57 M(-54.0%) |
| Sept 2014 | - | -$7.88 M(-90.2%) | -$122.96 M(-7.6%) |
| June 2014 | - | -$80.53 M(+1144.2%) | -$133.10 M(<-9900.0%) |
| Mar 2014 | - | -$6.47 M(-77.0%) | $610.00 K(-100.6%) |
| Dec 2013 | -$101.43 M(-437.2%) | -$28.08 M(+55.8%) | -$101.43 M(+146.6%) |
| Sept 2013 | - | -$18.02 M(-133.9%) | -$41.13 M(+72.9%) |
| June 2013 | - | $53.18 M(-149.0%) | -$23.79 M(-70.2%) |
| Mar 2013 | - | -$108.52 M(-436.7%) | -$79.72 M(-365.1%) |
| Dec 2012 | $30.08 M(-73.9%) | $32.23 M(-4839.0%) | $30.08 M(+28.6%) |
| Sept 2012 | - | -$680.00 K(-75.3%) | $23.40 M(-66.4%) |
| June 2012 | - | -$2.75 M(-313.9%) | $69.56 M(-23.7%) |
| Mar 2012 | - | $1.29 M(-95.0%) | $91.15 M(-20.8%) |
| Dec 2011 | $115.06 M(-154.0%) | $25.54 M(-43.8%) | $115.06 M(+53.3%) |
| Sept 2011 | - | $45.48 M(+141.6%) | $75.05 M(-1.6%) |
| June 2011 | - | $18.83 M(-25.3%) | $76.26 M(+113.9%) |
| Mar 2011 | - | $25.21 M(-274.2%) | $35.65 M(-116.7%) |
| Dec 2010 | -$213.04 M(-1299.7%) | -$14.47 M(-131.0%) | -$213.04 M(+17.2%) |
| Sept 2010 | - | $46.70 M(-314.4%) | -$181.78 M(-24.1%) |
| June 2010 | - | -$21.78 M(-90.3%) | -$239.56 M(+21.3%) |
| Mar 2010 | - | -$223.49 M(-1430.8%) | -$197.42 M(-1211.7%) |
| Dec 2009 | $17.76 M(-217.8%) | $16.79 M(-251.5%) | $17.76 M(+1740.2%) |
| Sept 2009 | - | -$11.09 M(-154.4%) | $965.00 K(-92.0%) |
| June 2009 | - | $20.36 M(-344.9%) | $12.05 M(-244.9%) |
| Mar 2009 | - | -$8.31 M | -$8.31 M |
| Dec 2008 | -$15.07 M(-45.4%) | - | - |
| Dec 2007 | -$27.61 M | - | - |
FAQ
- What is Ironwood Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly CFI year-on-year change?
- What is Ironwood Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals TTM CFI year-on-year change?
What is Ironwood Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of IRWD is -$1.03 B
What is the all time high annual CFI for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual cash flow from investing activities is $151.46 M
What is Ironwood Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of IRWD is -$16.00 K
What is the all time high quarterly CFI for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly cash flow from investing activities is $88.06 M
What is Ironwood Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, IRWD quarterly cash flow from investing activities has changed by +$4.17 M (+99.62%)
What is Ironwood Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of IRWD is -$4.33 M
What is the all time high TTM CFI for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high TTM cash flow from investing activities is $151.46 M
What is Ironwood Pharmaceuticals TTM CFI year-on-year change?
Over the past year, IRWD TTM cash flow from investing activities has changed by +$1.02 B (+99.58%)